Evidence map›Paper›PMID 39315032›Full record

ArticleRSC advances2024

Effects on molecular interactions of hollow gold nanoparticles and antibody for sensitizing P24 antigen determination.

Tao Wang, Chuanjiang Ran, Xinyue He, Shengzhou Li, Hongguang Xiang, Yan Shen, Jue Wang, Hongxia Wei

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tao WangDepartment of Clinical Laboratory, Second People's Hospital of Taixing City Jiangsu Province 225400 China.
Chuanjiang RanDepartment of Pharmaceutics, School of Pharmacy, China Pharmaceutical University Nanjing 210019 Jiangsu Province China.
Xinyue HeDepartment of Pharmaceutics, School of Pharmacy, China Pharmaceutical University Nanjing 210019 Jiangsu Province China.
Shengzhou LiDepartment of Pharmaceutics, School of Pharmacy, China Pharmaceutical University Nanjing 210019 Jiangsu Province China.
Hongguang XiangDepartment of Pharmaceutics, School of Pharmacy, China Pharmaceutical University Nanjing 210019 Jiangsu Province China.
Yan ShenDepartment of Pharmaceutics, School of Pharmacy, China Pharmaceutical University Nanjing 210019 Jiangsu Province China.
Jue WangNational Institutes for Food and Drug Control 2 Tiantan Xili, Dongcheng District Beijing 100050 China myxwj2007@163.com +86-10-67095126.ORCID https://orcid.org/0000-0002-5050-427X
Hongxia WeiDepartment of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine Nanjing 210003 China wghongxia@sina.com +86-13851507368.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, with the rapid development of point-of-care testing, the application of lateral flow immunochromatography assay (LFIA) has become increasingly widespread. The key to the success of these detection technologies is the effective binding with diagnostic materials and detection antibody proteins. Although many researchers have tried to optimize antibody binding, a universally accepted strategy that can provide maximum performance has not been determined. In this study, the HIV infection P24 antigen was selected as the detection biomarker. Then the binding mechanism between hollow gold nanoparticles as diagnostic materials and detection antibodies was explored through dynamic light scattering, Fourier transform infrared spectroscopy, circular dichroism spectroscopy, and other methods. It was found that the binding efficiency is related to the change in protein secondary conformation during binding, hydrogen bonding, and van der Waals force maintain the binding mechanism between antibodies and nanoparticles. The main forces of particle complexation and the main binding site of the antibody were discussed and analyzed. Finally, an immunochromatographic system was constructed to evaluate the significant advantages of this platform compared to the common colloidal gold immunochromatographic system.

Identifiers

PMID39315032
PMCPMC11418390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.